Clinical Roundup Targeted drug could benefit pediatric and young adult patients with invasive soft tissue cancer November 21, 2025Vol.51 No.43
Cancer Policy Trump signs order to use AI to accelerate pediatric cancer research October 03, 2025Vol.51 No.36By Claire Marie Porter
FreeIn the Archives Michael Link reflects on his ASCO presidential term, concerns for the future of oncology—and hope for children with cancer September 26, 2025Vol.51 No.35
How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest June 27, 2025Vol.51 No.25By Paul Goldberg
In Brief Thyme Care triples multidisciplinary care team with increased focus on survivorship June 13, 2025Vol.51 No.23
Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s MercyWhistleblower lawsuit alleges wrongful firing April 11, 2025Vol.51 No.14By Claire Marie Porter
Clinical Roundup Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds April 11, 2025Vol.51 No.14
Drugs & Targets FDA approves cabozantinib for patients 12 and up with pNET and epNET March 28, 2025Vol.51 No.12
In Brief Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders March 21, 2025Vol.51 No.11
Clinical Roundup Classifying childhood brain cancers by immune response may improve diagnostics and treatments March 21, 2025Vol.51 No.11
